Berklee held a symposium about the coronavirus (COVID-19) on June 11 featuring experts from the fields of medicine, biotechnology, and higher education. This discussion will deepen understanding of the current state of vaccine development, testing and social distancing procedures, therapeutics, and how these and other considerations inform decisions about Berklee’s fall semester.
Moderator
Susan Whitehead, Chair, Berklee Board of Trustees
Panelists
Noubar Afeyan, Ph.D., Cofounder and Chair of Moderna, Inc.
Dr. Paula Johnson, President, Wellesley College
Dr. Laura Kogelman, Director, Infectious Diseases Clinic and Director, Traveler's Health Service, Tufts Medical Center; Associate Professor, Tufts University School of Medicine
Roger H. Brown, President, Berklee
Moderator
Susan Whitehead, Chair, Berklee Board of Trustees
Panelists
Noubar Afeyan, Ph.D., Cofounder and Chair of Moderna, Inc.
Dr. Paula Johnson, President, Wellesley College
Dr. Laura Kogelman, Director, Infectious Diseases Clinic and Director, Traveler's Health Service, Tufts Medical Center; Associate Professor, Tufts University School of Medicine
Roger H. Brown, President, Berklee
- Category
- Academic
Sign in or sign up to post comments.
Be the first to comment